Advertisement

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Stefano Luminari, Michele Merli, Sara Rattotti, Vittoria Tarantino, Luigi Marcheselli, Federica Cavallo, Marzia Varettoni, Benedetta Bianchi, Francesco Merli, Alessandra Tedeschi, Giuseppina Cabras, Francesca Re, Carlo Visco, Marcia Torresan Delamain, Emanuele Cencini, Michele Spina, Simone Ferrero, Angela Ferrari, Marina Deodato, Donato Mannina, Ombretta Annibali, Angela Rago, Lorella Orsucci, Irene Defrancesco, Marco Frigeni, Marina Cesaretti and Luca Arcaini

Article Information

Citation 
vol. 134 no. 10 798-801
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted February 25, 2019
  • Accepted June 25, 2019
  • Published online September 5, 2019.

Article Versions


Contributors 
  • Stefano Luminari, 1Division of Hematology, Azienda Unità Sanitaria Locale Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Reggio Emilia, Reggio Emilia, Italy; 2Surgical, Medical and Dental Department of Morphological Sciences related to the Transplant, Oncology and Regenerative Medicine Department, University of Modena and Reggio Emilia, Modena, Italy;
  • Michele Merli, 3Division of Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi–Azienda Socio-Sanitaria Territoriale Sette Laghi, University of Insubria, Varese, Italy;
  • Sara Rattotti, 4Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;
  • Vittoria Tarantino, 5PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy; 6Lymphoma Unit, Department of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy;
  • Luigi Marcheselli, 7Fondazione Italiana Linfomi, Modena, Italy;
  • Federica Cavallo, 8Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin, Italy; 9Division of Hematology 1, Azienda Ospedaliera Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy;
  • Marzia Varettoni, 4Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;
  • Benedetta Bianchi, 3Division of Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi–Azienda Socio-Sanitaria Territoriale Sette Laghi, University of Insubria, Varese, Italy;
  • Francesco Merli, 1Division of Hematology, Azienda Unità Sanitaria Locale Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Reggio Emilia, Reggio Emilia, Italy;
  • Alessandra Tedeschi, 10Department of Hematology, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy;
  • Giuseppina Cabras, 11Division of Hematology, Ospedale Oncologico Armando Businco, Cagliari, Italy;
  • Francesca Re, 12Division of Hematology, Azienda Ospedaliero–Universitaria di Parma, Parma, Italy;
  • Carlo Visco, 13Section of Hematology, Department of Medicine, University of Verona, Verona, Italy;
  • Marcia Torresan Delamain, 14Center of Hematology and Hemotherapy, Department of Internal Medicine, Faculty of Medicine, State University of Campinas, Campinas, Brazil;
  • Emanuele Cencini, 15Division of Hematology, Department of Oncology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy;
  • Michele Spina, 16Division of Medical Oncology A, National Cancer Institute, Aviano, Italy;
  • Simone Ferrero, 8Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin, Italy; 9Division of Hematology 1, Azienda Ospedaliera Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy;
  • Angela Ferrari, 1Division of Hematology, Azienda Unità Sanitaria Locale Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Reggio Emilia, Reggio Emilia, Italy;
  • Marina Deodato, 10Department of Hematology, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy;
  • Donato Mannina, 17Department of Hematology, Azienda Ospedaliera Papardo, Messina, Italy;
  • Ombretta Annibali, 18Unit of Hematology, Stem Cell Transplantation, Transfusion Medicine and Cellular Therapy, University Campus Bio-Medico, Rome, Italy;
  • Angela Rago, 19Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy;
  • Lorella Orsucci, 20Division of Hematology 2, AOU Città della Salute e della Scienza di Torino, Turin, Italy; and
  • Irene Defrancesco, 4Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;
  • Marco Frigeni, 21Department of Molecular Medicine, University of Pavia, Pavia, Italy
  • Marina Cesaretti, 7Fondazione Italiana Linfomi, Modena, Italy;
  • Luca Arcaini, 4Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 21Department of Molecular Medicine, University of Pavia, Pavia, Italy

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output